Categories AlphaGraphs, Analysis, Technology

Intuit beats Q2 earnings estimate by 23 cents

Payroll solutions provider Intuit Inc. (INTU) on Thursday reported a 12% increase in second-quarter revenue to $1.5 billion, helped by a 38% jump in Small Business Online Ecosystem revenue. Analysts had projected total revenue of just $1.48 billion for Q2.

The stock gained 0.4% during after-market trading following the announcement. INTU shares have gained 35% in the past 12 months and are currently trading at an all-time high.

Picture Courtesy: Intuit

Net income rose to 72 cents per share from 70 per share a year ago. Excluding for one-time costs, the company earned $1 per share, which surpassed the street expectation of 77 cents per share.

CEO Sasan Goodarzi said, “Small Business and Self-Employed Group delivered another strong quarter led by our Online Ecosystem. We are solving top customer problems with offerings that deliver better money outcomes, smarter decisions and enhanced connections for those leveraging the QuickBooks platform.”

QuickBooks Online subscribers grew 38%, ending the quarter with nearly 3.9 million subscribers.

An infographic on Intuit's second quarter 2019 earnings results

Looking ahead into the third quarter, the company expects adjusted earnings in the range of $5.35 to $5.40 per share and revenue growth in the range of 10% to 12%.

For the full year 2019, Intuit reiterated its adjusted earnings guidance in the range of $6.40 to $6.50 per share. Revenues outlook projection was unchanged at $6.530 billion to $6.630 billion.

Market experts remain optimistic about the company’s mid-market targeting QuickBooks Online Advanced service. Customers would be benefited by the easy discovery of critical payments functionality in the QuickBooks Payments that was redesigned recently.

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text 

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top